Börse von finanzen.net | Aktien-Nachrichten | Marktberichte

DAX	6.050	-3,4%	Dow	12.119	-2,2%	Euro	1,2432	0,6%
ESt50	2.069	-2,4%	Nas	2.748	-2,8%	Öl	98,82	-2,8%
TDax	730,9	-2,7%	Nikkei	8.440	-1,2%	Gold	1.626	4,2%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds	Senden
Historisch	Realtime Push	myNews neu		IR-Daten	Anleihen	handeln

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

myNews neu

handeln

06.08.08	Bioject Reports Second-Quarter 2008 Financial Results
30.07.08	Bioject to Report Second Quarter 2008 Financial Results
22.07.08	Bioject to Be Transferred to the over-the-Counter Bulletin Board
17.07.08	Biojector(R)2000 Data Presented in Vical's Pandemic Influenza DNA Vaccine Human Trial
23.06.08	Bioject Announces Long-Term Agreement with Merial Limited
05.06.08	Bioject and ImmunoVaccine Technologies Announce Research Collaboration
02.06.08	Bioject Medical Technologies Inc. Annual Shareholders' Meeting Thursday, June 5, 2008
27.05.08	Biojector(R)2000 Technology Put to the Test in CDC Flu Vaccine Study
23.05.08	Bioject Receives Nasdaq Staff Determination
07.05.08	Bioject Reports First Quarter 2008 Financial Results

01.05.08	Bioject to Report First Quarter 2008 Financial Results
17.03.08	Bioject Reports December 31, 2007 Results and Initiates New Strategy
10.03.08	Bioject to Report Fourth Quarter and Year-End 2007 Financial Results
23.01.08	Bioject Note Holders Convert at Premium with Series F Convertible Preferred Stock
03.01.08	Bioject President and CEO to Present at OneMedPlace Emerging Healthcare Technologies Finance Forum
06.12.07	Bioject at the Forefront of Product Development with Use of Biojector(R) 2000 in Vical's Expanded DNA Vaccine Clinical Trial
06.12.07	Bioject Secures Additional Funding to Reach Total of $1.2M Raised with Strong Support from Signet Healthcare Partners
20.11.07	Bioject Announces Convertible Debt Financing
05.11.07	Bioject President and CEO to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
31.10.07	Bioject Reports Third-Quarter 2007 Results
26.10.07	Bioject to Report Third Quarter 2007 Financial Results
11.10.07	Bioject Announces New Supply Agreement with Merck Serono
05.10.07	Bioject Files Form 8-K Describing Employment Agreement with New Chief Executive Officer
03.10.07	Bioject Announces Roche and Trimeris Update on the Use of Fuzeon(R) with Biojector(R) 2000
02.10.07	Bioject Announces Hiring of President and Chief Executive Officer
07.09.07	Bioject Completes Financing with Partners for Growth
22.08.07	Two Separate Studies Presented at the AIDS Vaccine 2007 Conference Show Improved Results with the Biojector(R)2000
08.08.07	Bioject Reports Second-Quarter 2007 Financial Results
01.08.07	Bioject to Report Second Quarter 2007 Financial Results
26.06.07	Biojector(R)2000 Technology Used in Oman Vaccine Study

Finanzen.net

Bioject Medical Technologies Aktie [WKN: 874950 / ISIN: US09059T2069]

Hinweis

Newssuche

ALLE Nachrichten zur Bioject Medical Technologies Inc (Oregon)Shs

Anzeige

ANZEIGE